Metabolic rate is lower in this group, so caloric deficit management requires more attention
124 The dual GLP-1/GIP receptor agonist tirzepatide ameliorated AD pathology in diabetic rat models by improving learning and memory, modulating cerebral glucose metabolism, promoting neurotrophic factor expression, and suppressing inflammatory responses
Personalized Treatment Plan: Based on the assessment, we will create a customized plan that incorporates semaglutide injections, nutritional guidance, and an exercise regimen
A statement that the patient was counseled on the nature of compounded drugs, storage, and potential side effects
Clinically, it is considered among the least concerning for long-term use